Clinical Trial Update: Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fast-acting insulin aspart delivered via the iLet insulin pump system in adults with Type 1 diabetes has been completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Fast-acting Insulin Aspart (insulin aspart)
• iLet insulin pump system

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11